Bingbing Lu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- RNA Research and Splicing
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- RNA modifications and cancer 3
- Metabolism, Diabetes, and Cancer 1
- Histone Deacetylase Inhibitors Research 1
- Oncology 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Zigang Dong (9 shared papers)Kangdong Liu (3 shared papers)Xuechao Jia (3 shared papers)Kai Li (1 shared paper)Ziyue Liu (1 shared paper)Fangfang Liu (2 shared papers)Yubo Zhai (1 shared paper)Yiu To Yeung (3 shared papers)
- Journals
- Journal of Experimental & Clinical Cancer Research (2 papers)Cancer Research (1 paper)Frontiers in Oncology (1 paper)EBioMedicine (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bingbing Lu
10 papers receiving 240 citations
Bingbing Lu's Hit Papers
Peers
Comparison fields: 5 of 55
- Cancer Research 60
- Molecular Biology 181
- Oncology 62
- Cell Biology 18
- Pulmonary and Respiratory Medicine 36
Countries citing papers authored by Bingbing Lu
This map shows the geographic impact of Bingbing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingbing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingbing Lu more than expected).
Fields of papers citing papers by Bingbing Lu
This network shows the impact of papers produced by Bingbing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingbing Lu. The network helps show where Bingbing Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingbing Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches Hit paper breakdown → | 2024 | 92 |
| 2 | 2019 | 34 | |
| 3 | 2018 | 31 | |
| 4 | 2023 | 28 | |
| 5 | 2020 | 19 | |
| 6 | 2020 | 15 | |
| 7 | 2023 | 12 | |
| 8 | 2020 | 9 | |
| 9 | 2022 | 1 | |
| 10 | 2019 | 1 |
About Bingbing Lu
Bingbing Lu is a scholar working on Molecular Biology, Oncology, Surgery, Pharmacology and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 242 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Inflammatory mediators and NSAID effects (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (60 citations), Molecular Biology (181 citations), Oncology (62 citations), Cell Biology (18 citations) and Pulmonary and Respiratory Medicine (36 citations). Bingbing Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zigang Dong, Kangdong Liu, Xuechao Jia, Kai Li, Ziyue Liu, Fangfang Liu, Yubo Zhai, Yiu To Yeung, Shuying Yin and Ann M. Bode. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Cancer Research, Frontiers in Oncology, EBioMedicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.